PT - JOURNAL ARTICLE AU - Yang, Guang AU - Parker, Ethan AU - Gorsi, Bushra AU - Liebowitz, Mark AU - Maguire, Colin AU - King, Jace B. AU - Coon, Hilary AU - Lopez-Larson, Melissa AU - Anderson, Jeffrey AU - Yandell, Mark AU - Shcheglovitov, Alex TI - Neurite outgrowth deficits caused by rare PLXNB1 mutation in pediatric bipolar disorder AID - 10.1101/2022.05.06.22274499 DP - 2022 Jan 01 TA - medRxiv PG - 2022.05.06.22274499 4099 - http://medrxiv.org/content/early/2022/05/20/2022.05.06.22274499.1.short 4100 - http://medrxiv.org/content/early/2022/05/20/2022.05.06.22274499.1.full AB - Pediatric Bipolar Disorder (PBD) is a severe mood dysregulation condition that affects 0.5–1% of children and teens in the United States. It is associated with recurrent episodes of psychosis and depression and an increased risk of suicidality. However, the genetics and neuropathology of PBD are largely unknown. Here, we used a combinatorial family-based approach to characterize the cellular, molecular, genetic, and network-level deficits associated with PBD. We recruited a PBD patient and three unaffected family members from a family with a history of psychiatric illnesses. Using resting-state functional magnetic resonance imaging (rs-fMRI), we detected altered resting-state functional connectivity in the patient as compared to the unaffected sibling. Using transcriptomic profiling of patient and control induced pluripotent stem cell (iPSC) derived telencephalic organoids, we found aberrant signaling in the molecular pathways related to neurite outgrowth. We corroborated the presence of neurite outgrowth deficits in patient iPSC-derived cortical neurons and identified a rare homozygous loss-of-function PLXNB1 variant (c.1360C>C; p.Ser454Arg) in the patient. Expression of wild-type PLXNB1, but not the variant, rescued neurite outgrowth deficit in patient neurons, and expression of the variant caused neurite outgrowth deficit in cortical neurons from PlxnB1 knock-out mice. These results indicate that dysregulated PLXNB1 signaling may contribute to an increased risk of PBD and other mood dysregulation-related disorders by disrupting neurite outgrowth and functional brain connectivity. Overall, the study established and validated a novel family-based combinatorial approach for studying cellular and molecular deficits in psychiatric disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Utah Neuroscience Initiative, the Utah Genome Project, and the NIH Developmental Biology Training Grant (T32HD007491).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of University of Utah gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors